Valuation: LanZhou Foci Pharmaceutical Co.,Ltd.

Market Cap 3.68B 543M 475M 438M 405M 768M 51.79B 781M 5.23B 2.06B 25.51B 2.04B 1.99B 87.71B P/E 2024
65.6x
P/E 2025 89.6x
Enterprise Value 3.2B 472M 413M 381M 352M 668M 45.05B 679M 4.55B 1.79B 22.19B 1.77B 1.74B 76.3B EV / Sales 2024
3.66x
EV / Sales 2025 4.3x
Free-Float
34.06%
Yield 2024
0.16%
Yield 2025 0.23%
1 day+0.84%
1 week-1.64%
Current month+5.87%
1 month-2.70%
3 months-16.84%
6 months-17.88%
Current year-16.55%
1 week 7.04
Extreme 7.04
7.5
1 month 6.63
Extreme 6.63
7.73
Current year 6.63
Extreme 6.63
11.02
1 year 6.63
Extreme 6.63
11.85
3 years 5.84
Extreme 5.84
11.85
5 years 5.84
Extreme 5.84
15.17
10 years 5.84
Extreme 5.84
15.17
Manager TitleAgeSince
Chief Executive Officer 62 2022-04-05
Director of Finance/CFO - 2022-12-01
Corporate Officer/Principal 52 2018-01-31
Director TitleAgeSince
Director/Board Member 71 2022-05-11
Director/Board Member 56 2020-01-01
Chairman 60 2014-05-07
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%-1.64%-14.57%-38.27% 543M
+0.95%-0.08%-12.82%-8.16% 12.85B
+2.42%+1.37%-33.43%-54.80% 4.79B
-0.02%-0.64%-6.89%-5.76% 4.4B
-7.84%-7.31%+12.48%-9.74% 3.68B
+2.11%-0.70%+4.02%-37.69% 3.82B
-0.58%+6.63%-8.69%-13.03% 3.26B
+0.28%+0.57%-11.39%+2.92% 3.1B
-0.77%+1.24%-7.85%-23.20% 2.41B
-0.32%+4.78%-5.40%+44.70% 1.8B
Average -0.29%-1.34%-8.45%-14.30% 4.07B
Weighted average by Cap. -0.00%-1.29%-9.69%-14.81%

Financials

2024 2025
Net sales 980M 145M 126M 117M 108M 204M 13.79B 208M 1.39B 547M 6.79B 543M 531M 23.35B 916M 135M 118M 109M 101M 191M 12.88B 194M 1.3B 511M 6.34B 507M 496M 21.81B
Net income 60.07M 8.86M 7.75M 7.15M 6.6M 12.53M 845M 12.74M 85.4M 33.54M 416M 33.26M 32.54M 1.43B 49.21M 7.26M 6.35M 5.86M 5.41M 10.26M 692M 10.43M 69.96M 27.47M 341M 27.25M 26.66M 1.17B
Net Debt -357M -52.67M -46.07M -42.49M -39.25M -74.47M -5.02B -75.72M -508M -199M -2.47B -198M -193M -8.51B -479M -70.64M -61.79M -57M -52.64M -99.89M -6.74B -102M -681M -267M -3.32B -265M -259M -11.41B
Logo LanZhou Foci Pharmaceutical Co.,Ltd.
Lanzhou Foci Pharmaceutical Co Ltd is a China-based company mainly engaged in the manufacture of traditional Chinese medicine. The Company's main businesses include the research and development, production and sales of Chinese patent medicines and health products, cultivation and sales of Chinese medicinal materials, processing and sales of Chinese herbal medicines, production and sales of medical devices such as protective masks, and others. The Company's products include Fufang Huangqi Jianpi Oral Liquid, Liuwei Dihuang Pills, Xiaoyao Pills, Xiangsha Yangwei Pills, Shenrong Guben Huanshao Pills, donkey-hide gelatin, Chinese herbal medicine slices, and others. The Company's products cover categories and fields such as tonic, cold, gastrointestinal, gynecology, and tranquilizing sleep.
Employees
1,332
Date Price Change Volume
26-07-10 CN¥7.210 +0.84% 3,801,500
26-07-09 CN¥7.150 -0.69% 2,444,478
26-07-08 CN¥7.200 +0.28% 2,672,619
26-07-07 CN¥7.180 -3.62% 3,564,700
26-07-06 CN¥7.450 +1.64% 4,054,200
  1. Stock Market
  2. Stocks
  3. 002644 Stock